Teva Pharmaceutical Industries (NYSE:TEVA) Stock Rating Lowered by StockNews.com
Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Thursday. A number of other equities analysts also recently commented on TEVA. Piper Sandler upped their target price on shares of Teva Pharmaceutical Industries from $23.00 […]
Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Thursday. A number of other equities analysts also recently commented on TEVA. Piper Sandler upped their target price on shares of Teva Pharmaceutical Industries from $23.00 […]
